EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Reirradiation for diffuse intrinsic pontine glioma in an upper middle-income country: does full dose improve outcomes?

Natália Dassi, Maria Luisa Sucharski Figueiredo, Francine Tesser Gamba, Marcos Devanir Silva da Costa, Ana Carolina Dos Santos Torquato, Jessica Benigno Rodrigues, Ronaldo Modesto de Souza Filho, Sergio Cavalheiro, Patricia Alessandra Dastoli, Frederico Adolfo Silva, Carlota Vitoria Blassioli Moraes, Silvia Regina Caminada de Toledo und 3 weitere

Child's Nervous System · 20.08.2026 · 42 (1)

DOI: 10.1007/s00381-026-07390-x ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Child's Nervous System, online erschienen am 20.08.2026. Verfasst von Natália Dassi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, IOP-GRAACC-Federal University of Sao Paulo, Pedro de Toledo Street, 572, Sao Paulo, 04039001, Brazil. natalia.dassi…. Hauptthemen laut MEDLINE: Diffuse Intrinsic Pontine Glioma, Brain Stem Neoplasms, Re-Irradiation. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal De São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Reirradiation (reRT) during diffuse intrinsic pontine glioma (DIPG) progression has emerged as a potential treatment strategy for prolonging survival.

Methods

This retrospective, single-center observational study was conducted on children diagnosed with DIPG between 2010 and 2025, and data from 58 were collected. Doses for reRT were as follows: 50–54 Gy (1.8–2.0 Gy daily/fractions) or 39 Gy (3 Gy daily/fractions). Overall survival (OS) was defined as the time from diagnosis to the date of death and reRT OS, reirradiation starting to death. The Kaplan–Meier method and log-rank test were used for survival analysis.

Results

The median age was 7.1 years (range 2.9–16.2 years). Twenty-six patients underwent a biopsy. The H3K27M mutation was the most prevalent in our study, followed by TP53 altered gene. Twenty-two patients underwent reRT at progression. The median time from initial treatment to reRT was 9.9 months (range 6.7 to 20.5 months). Seven of the 22 patients received reRT at a dose of 39 Gy while 14 at doses of 50–54 Gy. The median OS from reRT to death was 5.8 months (range, 0.9–18.3 months). Patients who received reRT had a longer OS compared to those who did not (median OS of 17.9 versus 9.8 months; p = 0.005). Longer time for progression (> 9 months) and dose of reRT > 50 Gy were statistically significantly correlated with better OS. Reirradiation was generally well-tolerated by all patients.

Conclusions

This study offers molecular insights into this tumor type and presents a therapeutic option with higher nominal doses reRT within a palliative context to prolong survival of these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diffuse Intrinsic Pontine GliomaBrain Stem NeoplasmsRe-IrradiationHumansChildFemaleChild, PreschoolMaleRetrospective StudiesAdolescentTreatment Outcome

Stichwörter der Autor:innen

Diffuse intrinsic pontine gliomaMolecular alterationsTumor biopsy

Autor:innen und Institutionen

  • Department of Pediatric Oncology, IOP-GRAACC-Federal University of Sao Paulo, Pedro de Toledo Street, 572, Sao Paulo, 04039001, Brazil. natalia.dassi@unifesp.br.
  • Department of Radiation Oncology, IOP-GRAACC-Federal University of Sao Paulo, Sao Paulo, Brazil.
  • Genetics Laboratory, IOP-GRAACC-Federal University of Sao Paulo, Sao Paulo, Brazil.
  • National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology - INCT BioOncoPed, Sao Paulo, Brazil.
  • Department of Neurosurgical Oncology, IOP-GRAACC-Federal University of Sao Paulo, Sao Paulo, Brazil.
  • Department of Pediatric Oncology, IOP-GRAACC-Federal University of Sao Paulo, Pedro de Toledo Street, 572, Sao Paulo, 04039001, Brazil.

Förderung

  • Universidade Federal De São Paulo

Zitieren

APA

Dassi, N., Figueiredo, M. L. S., Gamba, F. T., da Costa, M. D. S., Dos Santos Torquato, A. C., Rodrigues, J. B., de Souza Filho, R. M., Cavalheiro, S., Dastoli, P. A., Silva, F. A., Moraes, C. V. B., de Toledo, S. R. C., Da Silva, N. S., Chen, M. J., & Cappellano, A. M. (2026). Reirradiation for diffuse intrinsic pontine glioma in an upper middle-income country: does full dose improve outcomes?. Child's Nervous System, 42(1). https://doi.org/10.1007/s00381-026-07390-x

Vancouver

Dassi N, Figueiredo MLS, Gamba FT, da Costa MDS, Dos Santos Torquato AC, Rodrigues JB, et al. Reirradiation for diffuse intrinsic pontine glioma in an upper middle-income country: does full dose improve outcomes?. Child's Nervous System. 2026;42(1). doi:10.1007/s00381-026-07390-x

BibTeX
@article{Dassi2026,
  author = {Dassi, Natália and Figueiredo, Maria Luisa Sucharski and Gamba, Francine Tesser and da Costa, Marcos Devanir Silva and Dos Santos Torquato, Ana Carolina and Rodrigues, Jessica Benigno and de Souza Filho, Ronaldo Modesto and Cavalheiro, Sergio and Dastoli, Patricia Alessandra and Silva, Frederico Adolfo and Moraes, Carlota Vitoria Blassioli and de Toledo, Silvia Regina Caminada and Da Silva, Nasjla Saba and Chen, Michael Jenwei and Cappellano, Andrea Maria},
  title = {Reirradiation for diffuse intrinsic pontine glioma in an upper middle-income country: does full dose improve outcomes?},
  journal = {Child's Nervous System},
  year = {2026},
  volume = {42},
  number = {1},
  doi = {10.1007/s00381-026-07390-x}
}
Kostenlos starten →